Russian company building blood products plant

Russia's Generium has started construction in the Vladimir region on what is being billed as Europe's largest biopharmaceutical plant. The facility is slated to make products that include antibodies, blood coagulants and albumin, Sputnik International reports. The work is slated to be complete in 2018. Report

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.